GDTC
GDTC
NASDAQ · Biotechnology

Cytomed Therapeutics Ltd

$1.17
+0.09 (+8.33%)
As of Feb 8, 2:27 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,977.8% upside
Low Target $15.00
Average Target $24.31
High Target $29.94
Current Price $1.17
Current
$1.17
Target
$24.31
$15.00 $24.31 avg $29.94
Scenario Analysis
Bear Case
$15.00
1,182.1%
Low target
Base Case
$24.31
+1,977.8%
Avg target
Bull Case
$29.94
+2,459.0%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$27.52
-95.7% from high
52-Week Low
$11.92
+-90.2% from low
Target vs 52W High
$24.31
-11.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 37 68% $257.58 +15.3%
AMGN
Amgen Inc
Hold 41 54% $190.87 -50.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.8%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 77% $438.34 -8.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.2%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -68.8%
INSM
Insmed Inc
Strong Buy 27 93% $143.40 -4.3%
BIIB
Biogen Inc
Hold 42 48% $91.45 -54.5%